Nine Chapters Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Nine Chapters Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-21	Closed	-$30K	–	613
2015 Q3	$30K	Sell	21 -15	-42%	-$28.9K	﹤0.01%	956
2015 Q2	$80K	Buy	36 +8	+29%	+$25.1K	0.01%	888
2015 Q1	$84K	Sell	28 -4	-13%	-$12.8K	0.01%	907
2014 Q4	$107K	Buy	32 +3	+10%	+$10.6K	0.01%	866
2014 Q3	$103K	Buy	29 +20	+222%	+$77.7K	0.01%	928
2014 Q2	$35K	Buy	+9	New	+$33.9K	﹤0.01%	913
2013 Q4	–	Sell	-8	Closed	-$33K	–	975
2013 Q3	$33K	Buy	+8	New	+$60K	﹤0.01%	723

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nine Chapters Capital Management's FRTX Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2015, closing a stake of 21 shares — an estimated $30K sold.

Nine Chapters Capital Management first reported a position in FRTX in Q3 2013 and held it in 7 quarters. The position peaked at $107K in Q4 2014. 41 funds tracked by Wall St. Rank hold FRTX as of Q4 2015.

Nine Chapters Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 21 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $30K.
Nine Chapters Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and held it in 7 quarters.
Nine Chapters Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $107K in Q4 2014.
41 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.